Insufficient FDA Resources: Levelling the Playing Field and Reducing Fraud by Altering Incentives

DSpace/Manakin Repository

Insufficient FDA Resources: Levelling the Playing Field and Reducing Fraud by Altering Incentives

Show simple item record

dc.contributor.advisor Hutt, Peter Barton en_US
dc.contributor.author McFarland, Joshua L. en_US
dc.date.accessioned 2012-06-07T20:07:40Z
dc.date.issued 2001 en_US
dc.identifier.citation Insufficient FDA Resources: Levelling the Playing Field and Reducing Fraud by Altering Incentives (2001 Third Year Paper) en
dc.identifier.uri http://nrs.harvard.edu/urn-3:HUL.InstRepos:8852104
dc.description.abstract This paper seeks to explore the problems illustrated by the Procter and Gamble orange juice example ; namely, the peculiar side effects of inadequate FDA funding upon competition and rule compliance. Part I of this paper will describe the problem in detail, exploring the FDA’s resources and responsibilities, their effects on competition and compliance, and the various externalities associated with this particular issue. Part II of this paper will discuss ways in which various industries have attempted to circumvent and supplement FDA regulation. Part III of this paper proposes a way in which limited FDA resources could be used more efficiently to encourage industry to notify the agency of violations while simultaneously encouraging violators to cease their offending behavior before formal FDA action is taken towards them or an industry leading scapegoat. My proposal seeks to alter the costs and benefits of FDA rule violation by increasing penalties when appropriate and making enforcement more likely, thus reducing the aggregate amount of rule violation and leveling the playing field. I argue that this goal can be accomplished without significant increases in FDA spending, and perhaps could even reduce spending and increase funding. en
dc.language.iso en_US en
dash.license LAA en_US
dc.subject Food and Drug Law en
dc.subject FDA en
dc.subject enforcement en
dc.title Insufficient FDA Resources: Levelling the Playing Field and Reducing Fraud by Altering Incentives en
dc.type Paper (for course/seminar/workshop) en_US
dc.date.available 2012-06-07T20:07:40Z

Files in this item

Files Size Format View
McFarland.pdf 181.6Kb PDF View/Open
McFarland.rtf 86.84Kb RTF file View/Open
McFarland.html 80.01Kb HTML View/Open

This item appears in the following Collection(s)

Show simple item record

 
 

Search DASH


Advanced Search
 
 

Submitters